Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis
NCT01387802 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 722
Last updated 2020-12-09
Summary
The current study will assess the real - life effectiveness of adalimumab in the management of Ankylosing Spondylitis (AS) with emphasis on the prevention and management of extra-articular manifestations.
Conditions
Sponsors & Collaborators
-
JSS Medical Research Inc.
collaborator INDUSTRY -
Cato Research
collaborator INDUSTRY -
AbbVie (prior sponsor, Abbott)
lead INDUSTRY
Principal Investigators
-
AbbVie Inc. · AbbVie
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-29
- Primary Completion
- 2019-12-16
- Completion
- 2019-12-16
Countries
- Canada
Study Locations
More Related Trials
-
Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
NCT00227227 ·Status: COMPLETED
-
Defining Remission With Etanercept in AS in Real Life Clinical Practice
NCT02202850 ·Status: COMPLETED
-
Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical Practice
NCT01111240 ·Status: COMPLETED
-
Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs
NCT01091675 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Oral Upadacitinib Tablets to Assess the Change in Disease Symptoms in Adult Canadian Participants With Moderate to Severe Rheumatoid Arthritis
NCT04574492 ·Status: COMPLETED
-
Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
NCT04507763 ·Status: COMPLETED
-
Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
NCT01421303 ·Status: COMPLETED
-
Study Evaluating Etanercept in Patients With Ankylosing Spondylitis
NCT00458185 ·Status: COMPLETED ·Phase: PHASE4
-
Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study
NCT02489760 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria
NCT01877239 ·Status: COMPLETED
-
Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
NCT04507776 ·Status: COMPLETED
-
Rheumatoid Arthritis Patients on Adalimumab to Evaluate Its Effect on Synovitis Using Ultrasonography in an Egyptian Population
NCT01782469 ·Status: TERMINATED
-
Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?
NCT00696059 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis
NCT00421915 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain
NCT00873730 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA
NCT03172325 ·Status: COMPLETED ·Phase: PHASE3
-
Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis
NCT04953871 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department
NCT01411215 ·Status: TERMINATED
-
Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis
NCT01412021 ·Status: COMPLETED
-
Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs
NCT03729674 ·Status: UNKNOWN
-
An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis
NCT00421980 ·Status: COMPLETED ·Phase: PHASE3
-
A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography
NCT00767325 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes
NCT01258738 ·Status: COMPLETED ·Phase: PHASE3
-
Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening
NCT01578850 ·Status: COMPLETED ·Phase: PHASE4
-
Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis
NCT01061723 ·Status: COMPLETED ·Phase: PHASE2